Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on June 1, 2026

Jun. 1, 2026

Constellation Software Inc. Confirms Closing of DerbySoft Acquisition Through Juniper Group

Indeterminate GlobeNewswire

Jun. 1, 2026

Refined Energy Corp. Clarifies Certain Promotional Disclosure

Indeterminate GlobeNewswire

Jun. 1, 2026

Discovery Completes Acquisition of Kidd Operations

Indeterminate GlobeNewswire

Jun. 1, 2026

Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Jun. 1, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Teva to Present at the Goldman Sachs Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

authID Announces its 2026 Annual Meeting to be Held on July 6, 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Global Writing Competition Offers $4,500 in Prizes to Indie Web Novel Writers

Indeterminate EIN Presswire

Jun. 1, 2026

Praxis Precision Medicines Provides Vormatrigine Program Update

Indeterminate GlobeNewswire

Jun. 1, 2026

Microchip Technology Appoints Mitch Little to Its Board of Directors

Indeterminate GlobeNewswire

Jun. 1, 2026

Microchip Provides Data Center Solutions Business Unit Revenue Information

Indeterminate GlobeNewswire

Jun. 1, 2026

Microchip Technology to Present at the B of A Securities Global Technology Conference 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Indeterminate GlobeNewswire

Jun. 1, 2026

Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère

Indeterminate GlobeNewswire

Jun. 1, 2026

Broadcom Connects the AI Edge with Comprehensive Multi-Gig Broadband and Wi-Fi 8 Innovations

Indeterminate GlobeNewswire

Jun. 1, 2026

Merlin, Inc. To Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire